$138.40
-0.54-0.39%
가까이에: Sep 25, 5:00 PM EST
$138.40
N/A
시간외: 4:30 PM EST
Benzinga
Benzinga
Benzinga
토요일, 9월 26
Neurocrine Biosciences Inc
NBIXNASDAQ
Neurocrine Biosciences Earnings & Forecasts
Neurocrine Biosciences (NBIX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Neurocrine Biosciences Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.10 | $1.61 | $2.09 | $1.87 |
| Actual | $2.85 | $1.94 | $1.88 | $2.17 |
| Surprise | +35.7% | +20.5% | -10.1% | +16.0% |
| Revenue | ||||
| Estimate | $876.6M | $763.1M | $786.7M | $745.8M |
| Actual | $959.0M | $814.5M | $805.5M | $794.9M |
| Surprise | +9.40% | +6.73% | +2.38% | +6.58% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.57 | $2.68 | $1.74 | $2.13 |
| Revenue | ||||
| Consensus | $1.04B | $1.08B | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved